All Posts Tagged With: "SNY"

Berkshire Hathaway’s Mystery $3.5bn Spending Spree

With the stock market in turmoil, it’s a good time to check in on what Warren Buffett is doing with his portfolio. Buffett’s Berkshire Hathaway Inc. (NYSE:BRK.A, BRK.B) has struggled in the first half of the year. Money Morning’s Jason Simpkins says $3.5 billion of Berkshire’s recent $4-billion shopping spree is still unaccounted for…

How to Profit from Biotech in Eastern Europe

It wasn’t long ago that we published several articles urging investors into the neglected biotech industry. Now Sara Nunnally over at Taipan Publishing says Central and Eastern Europe is a hot region for the sector right now. Big pharma is also looking to enter the rapidly growing market for generic drugs. And a popular way to establish a foothold in the region is through acquisitions of local firms.

How to Profit from the Fall of Big Pharma

Big Pharma is in trouble. Generic competition, patent expirations and slowing sales are all eating into profits.

So how can you turn a profit in this turbulent sector? By investing in contract research organisations, or CROs, says biotech expert Rob Fannon. When the big pharmaceutical companies outsource research to CROs they get paid whether or not the new drugs ever make it to market.

There’s another way to profit too - contract sales organizations, or CSOs. They’re another way for Big Pharma to outsource, but instead of doing research they sell.

Receive These Valuable Investing Strategy Resources to Your Inbox Courtesy of Contrarian Profits

    Subscribe
We respect your privacy.
Choose any of the FREE subscription services below that you'd like to receive, enter your email address, and click 'subscribe'.
Contrarian Profits

The Daily Reckoning



Select Edition:
Penny Sleuth

Money Morning

Investor's Daily Edge

Money Morning UK

Investment U

Whiskey and Gunpowder

Taipan Daily

Offshore A-Letter

Today's Financial News

International Living

The Smart Profits Report

Spiritual Wealth